With Thursday approval from the U.S. Food and Drug Administration for Cobenfy, adults living with schizophrenia will have ...

Teens and adults with autism and disabilities can be so hard ... The aromatherapy aspect of the therapy dough makes it multi-sensory, which I love! 11. iTunes Gift Card-One of my mom-friends posted, ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) ...

After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with ...

Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.

UCB, a global biopharmaceutical company, today announced the first presentation of two-year data from the Phase 3 studies, BE HEARD I and BE HEARD II, and their open-label extension, evaluating the ...

Patient randomization is underway in SONATA-HCM clinical trial evaluating Lexicon’s novel dual SGLT1 and SGLT2 inhibitor in this underserved and growing patient population Study design intended to ...

A recent trial shows that people with depression experienced greater symptom relief after 6 months of treatment with ...

With the global population aging rapidly, sarcopenia, a condition that affects millions of older adults and severely ...

With the global population aging rapidly, sarcopenia, a condition that affects millions of older adults and severely diminishes their quality of life, is emerging as an urgent public health issue.

Positive Phase III Results for Genentech’s Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis ...